Intranasal administration of the GHRP hexarelin accelerates growth in short children

Clinical Endocrinology

Volumn 43, Issue 5, 1995, Pages 631-635

  Laron, Z ^a   Frenkel, J ^a   Deghenghi, R ^a   Anin, S ^a   Klinger, B ^a   Silbergeld, A ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GONADORELIN DERIVATIVE; HEXARELIN; SOMATOMEDIN C;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SHORT STATURE; SKINFOLD THICKNESS;

EID: 0028884562     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.1995.tb02929.x     Document Type: Article

References (31)

1. Aloi, J.A., Gertz, B.J., Hartman, M.L., Huhn, W.C., Pezzoli, S.S., Wittreich, J.M., Krupa, D.A. & Thorner, M.O. (1994) Neuroendocrine responses to a novel growth hormone secretagogue, L‐692,429, in healthy older subjects. Journal of Clinical Endocrinology and Metabolism, 79, 943–949.
2. Alster, D.L., Bowers, C.Y., Jaffe, C.A., Ho, P.J. & Barkan, A.L. (1993) The growth hormone (GH) response to GH‐releasing peptide (His‐D‐Trp‐Ala‐Trp‐D‐Phe‐Lys‐NH 2, GH‐releasing hormone, and thyrotropin‐releasing hormone in acromegaly. Journal of Clinical Endocrinology and Metabolism, 11, 842–845.
3. Aran, O., Laron, Z., Galatzer, A., Nagelberg, N. & Rubicsek, Y. (1995) Is short stature a handicap‐legal and rehabilitation aspects. In Limb Lengthening‐For Whom, When and How? (eds Z. Laron, S. Mastragostino, C. Romano, A. Cohen & S. Boero), pp. 131–135. Freund Publishing House Ltd., London‐Tel Aviv.
4. Bowers, C.Y. (1993) GH releasing peptides‐structure and kinetics. Journal of Pediatric Endocrinolology, 6, 21–31.
5. Bowers, C.Y., Alster, D.K. & Frentz, J.M. (1992) The growth hormone‐releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. Journal of Clinical Endocrinology and Metabolism, 14, 292–298.
6. Bowers, C.Y., Momany, F.A., Reynolds, G.A. & Hong, A. (1984) On the in vitro and in vivo activity of a new synthetic Hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 114, 1537–1545.
7. Bowers, C.Y., Reynolds, G.A., Durham, D., Barrera, C.M., Pezzolli, S.S. & Thorner, M.O. (1990) Growth hormone (GH)‐releasing peptide stimulates GH release in normal men and acts synergistically with GH‐releasing hormone. Journal of Clinical Endocrinology and Metabolism, 70, 975–982.
8. Cheng, K., Chan, W.W.S., Barreto, A., Convey, E.M. & Smith, R.G. (1989) The synergistic affects of His‐o‐Trp‐Ala‐Trp‐o‐Phe‐Lys‐NH 2 on intracellular adenosine 3′5′‐monophosphate accumulation in rat primary pituitary cell culture. Endocrinology, 124, 2791–2798.
9. Deghenghi, R., Cananzi, M., Battisti, C., Locatelli, V. & Muller, E.E. (1992) Hexarelin (EP23905)‐a superactive growth hormone releasing peptide. Journal of Endocrinological Investigation, 15 (Suppl. 4), 45 (A36). 2791–2798.
10. Deghenghi, R., Canazi, M.M., Torsello, A., Battisti, C., Muller, E.E. & Locatelli, V. (1994) GH‐releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sciences, 54, 1321–1328.
11. Frenkel, J., Silbergeld, A., Deghenghi, R. & Laron, Z. (1995) Short term effect of intranasal administration of Hexarelin‐a synthetic growth hormone‐releasing peptide. Preliminary communication. Journal of Pediatric Endocrinology and Metabolism, 8, 43–45.
12. Gertz, B.J., Barrett, J.S., Eisenhandler, R., Krupa, D.A., Wittreich, J.M., Seibold, J.R. & Schneider, S.H. (1993) Growth hormone response in man to L‐692,429, a novel nonpeptide mimic of growth hormone‐releasing peptide‐6. Journal of Clinical Endocrinology and Metabolism, 11, 1393–1397.
13. Ghigo, E., Arvat, E., Gianotti, L., Ramunni, J., Di Vito, L., Imbimbo, B.P., Lenaerts, V., Deghenghi, R. & Camanni, F. (1994) Growth hormone‐releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. Journal of Clinical Endocrinology and Metabolism, 18, 693–698.
14. Greulich, W.W. & Pyle, S.I. (1959) Radiographic Atlas of Skeletal Development of Hand and Wrist. Stanford University Press, Stanford.
15. Hayashi, S., Okimura, Y., Yagi, H., Ichiyama, T., Takeshima, Y., Shakutsui, S., Oohashi, S., Bowers, C.Y. & Chihara, K. (1991) Intranasal administration of His‐o‐Trp‐Ala‐Trp–Phe‐Lys‐NH 2 (growth hormone releasing peptide) increased plasma growth hormone and insulin‐like growth factor‐I levels in normal men. Endocrinologia Japonica, 38, 15–21.
16. Josefsberg, Z., Kauli, R., Keret, R., Brown, M., Bialik, O., Greenberg, D. & Laron, Z. (1983) Tests for hGH secretion in childhood. Comparison of response of growth hormone to insulin hypoglycemia and to arginine in children with constitutional short stature in different pubertal stages. In Pediatric and Adolescent Endocrinology. Volume 12. Evaluation of Growth Hormone Secretion (eds Z. Laron & O. Butenandt) pp. 66–74. S Barger, Basel.
17. Karp, M., Laron, Z. & Doron, M. (1973) Insulin secretion in children with constitutional familial short stature. Journal of Pediatrics, 83, 241–246.
18. Kirk, J.M.W., Trainer, P.J., Majrowski, W.H., Murphy, J., Savage, M.O. & Besser, G.M. (1994) Treatment with GHRH(1–29)NH 2 in children with idiopathic short stature induces a sustained increase in growth velocity. Clinical Endocrinology, 41, 487–493.
19. Klinger, B. & Laron, Z. (1994) Renal function in Laron Syndrome patients treated by IGF‐I. Pediatric Nephrology, 8, 684–688.
20. Laron, Z. (1993) Somatomedin I in clinical use: facts and potential. Drugs, 45, 1–8.
21. Laron, Z., Bowers, C.Y., Hirsch, D., Almonte, A.S., Pelz, M., Keret, R. & Gil‐Ad, I. (1993) Growth hormone‐releasing activity of growth hormone‐releasing peptide‐1 (a synthetic heptapeptide) in children and adolescents. Acta Endocrinologica, 129, 424–426.
22. Laron, Z. & Butenandt, O. (1991) Optimum use of growth hormone in children. Drugs, 42, 1–8.
23. Laron, Z., Frenkel, J., Gil‐Ad, I., Klinger, B., Lubin, E., Wuthrich, P., Boutignon, F., Lenaerts, V. & Deghenghi, R. (1994) Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin). Clinical Endocrinology, 41, 539–541.
24. Laron, Z., Frenkel, J. & Silbergeld, A. (1995) Growth hormonereleasing peptide‐Hexarelin‐in children. Biochemical and growth promoting effects. In Growth Hormone Secretagogues (eds B.B. Bercu & R.F. Walker) Springer Verlag, New York (in press).
25. Laron, Z. & Klinger, B. (1994) IGF‐I treatment of adult patients with Laron Syndrome: preliminary results. Clinical Endocrinology, 41, 631–638.
26. Laron, Z., Klinger, B., Jensen, L.T. & Erster, B. (1991) Biochemical and hormonal changes induced by one week of administration of rIGF‐I to patients with Laron type dwarfism. Clinical Endocrinology, 35, 145–150.
27. Laron, Z. & Mannheimer, S. (1966) Measurement of human growth hormone. Description of the method and its clinical applications. Israel Journal of Medical Sciences, 2, 115–119.
28. Laron, Z., Topper, E. & Gil‐Ad, I. (1983) Oral clonidine‐a simple, safe and effective test for growth hormone secretion. In Pediatric and Adolescent Endocrinology. Volume 12, Evaluation of Growth Hormone Secretion (eds Z. Laron & O. Butenandt), pp. 103–121. S. Karger, Basel.
29. Momany, F.A., Bowers, C.Y., Reynolds, G.A., Hong, A. & Newlander, K. (1984) Conformational energy studies and in vitro and in vivo activity data on active GH releasing peptides. Endocrinology, 114, 1531–1536.
30. Stabler, B. & Underwood, L.E. (1994) Growth, stature and adaptation. In Behavioral, Social and Cognitive Aspects of Growth Delay. University of North Carolina at Chapel Hill Press, Chapel Hill, USA.
31. Tanner, J.M., Whitehouse, R.H. & Takaishi, M. (1966) Standards from birth to maturity for height, weight, height velocity and weight velocity in British children. Archives of Diseases in Childhood, 41, 613–635.